Document is current
Any future updates will be listed below
-
Authors
Seegobin, Nidhi
McCoubrey, Laura E.
Vignal, Cécile
Waxin, Christophe
Abdalla, Youssef
Fan, Yue
Awad, Atheer
Murdan, Sudaxshina
Basit, Abdul W. https://orcid.org/0000-0002-5368-6603
-
Funding
Funding for this research was provided by:
Engineering and Physical Sciences Research Council (EP/S023054/1)
Interreg (Site Drug 2S07-033)
- License Information
-
More Information
Article History
Accepted: 18 October 2024
First Online: 11 November 2024
Declarations
:
: This study was performed in accordance with the approval from the Ethics Committee in Animal Experimentation Nord-Pas de Calais (CEEA75) which was approved by the French ministry for higher education and research. The CEEA75 carries out its activity according to the principles of European directive 2010/63/EU (transposed into French law 2013/2/1/AGRG1238767A) and the “National Charter on the ethics of animal experimentation” while respecting the recommendations for specific procedures issued by the National Ethics Reflection Committee on animal experimentation. All institutional and national guidelines for the care and use of laboratory animals were followed. As this study did not involve human subjects, consent to participate was not applicable.
: Not applicable.
: The authors have no relevant financial or non-financial interests to disclose. The content of this paper does not reflect the views of GSK.
